BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37691949)

  • 21. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
    J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.
    Martinet L; Le Guellec S; Filleron T; Lamant L; Meyer N; Rochaix P; Garrido I; Girard JP
    Oncoimmunology; 2012 Sep; 1(6):829-839. PubMed ID: 23162750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
    Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
    J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression/Recurrence-Free Survival 2 in Adjuvant Melanoma.
    Augustin RC; Luke JJ
    NEJM Evid; 2022 Nov; 1(11):EVIDe2200240. PubMed ID: 38319859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nodular primary cutaneous melanoma is associated with PD-L1 expression.
    Giavina-Bianchi M; Giavina-Bianchi P; Sotto MN; Rodig S; Mihm M; Festa Neto C; Duncan LM; Kalil J
    Eur J Dermatol; 2020 Aug; 30(4):352-357. PubMed ID: 32969795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.
    Avram G; Sánchez-Sendra B; Martín JM; Terrádez L; Ramos D; Monteagudo C
    Histopathology; 2013 Dec; 63(6):852-61. PubMed ID: 24102908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review: dendritic cell immunotherapy for melanoma.
    Hadzantonis M; O'Neill H
    Cancer Biother Radiopharm; 1999 Feb; 14(1):11-22. PubMed ID: 10850282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules.
    Moussion C; Girard JP
    Nature; 2011 Nov; 479(7374):542-6. PubMed ID: 22080953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
    Saberian C; Amaria RN; Najjar AM; Radvanyi LG; Haymaker CL; Forget MA; Bassett RL; Faria SC; Glitza IC; Alvarez E; Parshottam S; Prieto V; Lizée G; Wong MK; McQuade JL; Diab A; Yee C; Tawbi HA; Patel S; Shpall EJ; Davies MA; Hwu P; Bernatchez C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34021033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus.
    Hangalapura BN; Oosterhoff D; Aggarwal S; Wijnands PG; van de Ven R; Santegoets SJ; van den Tol MP; Hooijberg E; Pereboev A; van den Eertwegh AJ; Curiel DT; Scheper RJ; de Gruijl TD
    J Immunother; 2010 Sep; 33(7):706-15. PubMed ID: 20664356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation with lymphocyte infiltration, but lack of prognostic significance of MECA-79-positive high endothelial venules in primary malignant melanoma.
    Sebestyén T; Mohos A; Liszkay G; Somlai B; Gaudi I; Ladányi A
    Melanoma Res; 2018 Aug; 28(4):304-310. PubMed ID: 29683859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.
    Sosman JA; Unger JM; Liu PY; Flaherty LE; Park MS; Kempf RA; Thompson JA; Terasaki PI; Sondak VK;
    J Clin Oncol; 2002 Apr; 20(8):2067-75. PubMed ID: 11956267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.
    Movassagh M; Spatz A; Davoust J; Lebecque S; Romero P; Pittet M; Rimoldi D; Liénard D; Gugerli O; Ferradini L; Robert C; Avril MF; Zitvogel L; Angevin E
    Cancer Res; 2004 Mar; 64(6):2192-8. PubMed ID: 15026362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment.
    Dillman RO; McClay EF; Barth NM; Amatruda TT; Schwartzberg LS; Mahdavi K; de Leon C; Ellis RE; DePriest C
    Cancer Biother Radiopharm; 2015 Jun; 30(5):187-94. PubMed ID: 26083950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy.
    Murphy GF; Radu A; Kaminer M; Berd D
    J Invest Dermatol; 1993 Mar; 100(3):335S-341S. PubMed ID: 8440919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High endothelial venules (HEVs) in immunity, inflammation and cancer.
    Blanchard L; Girard JP
    Angiogenesis; 2021 Nov; 24(4):719-753. PubMed ID: 33956259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
    Vella G; Guelfi S; Bergers G
    Front Immunol; 2021; 12():736670. PubMed ID: 34484246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cell gene therapy.
    Onaitis M; Kalady MF; Pruitt S; Tyler DS
    Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.